Observed Signal · Oct 24, 2025 · Funding · Source: Trending Topics · Impact: 2/5 · Sentiment: Neutral
Austrian HealthTech VC Calm/Storm Closes €30M Fund
Vienna-based healthtech investor Calm/Storm has reached the final close of its second fund with €30 million. The capital will back early-stage European healthtech startups, requiring at least 75% of portfolio companies to be registered in Europe at investment time. About 70% of limited partners from the €20 million first fund re-joined, alongside new investors including SwissHealth Ventures, Natural X Health Ventures, Bertelsmann Investments, and Raiffeisen-Landesbank Steiermark. The fund has already invested in 25 companies, with an average ticket size of €500,000—double that of the first fund. Focus areas include digital health, prevention, consumer health, and AI-driven infrastructure for healthcare providers. Co-investments with LPs and venture partners exceed 120 deals.
Niche VC fund close in healthtech with AI focus; limited direct impact on AdTech/MarTech industry.
Track Real-Time Financials Signals & Market Shifts
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Calm/Storm closed its second fund at €30 million.
- 70% of LPs from the first fund participated again.
- New investors include SwissHealth Ventures, Natural X Health Ventures, Bertelsmann Investments, and Raiffeisen-Landesbank Steiermark.
- Average ticket size is €500,000, double the first fund.
- The fund has invested in 25 companies, including Aeon Life and Aiomics.
Ontology Mapping & Concepts
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
SCHUFA Reports More Payment Problems, Small Loans Rise
According to the SCHUFA Risk and Credit Compass 2026, the share of German consumers with registered payment disruptions rose from 7.9% to 8.1% in the past year. The number of first-time payment defaults increased by about 12% compared to the previous year. Private insolvency applications grew by 8.3% to around 88,000, and the number of garnishment protection accounts reached a record high of 2.82 million. Regionally, Bremen (11.2%), Berlin (10.1%), and North Rhine-Westphalia (9.9%) had the highest rates of affected consumers, while Bavaria (6%) and Baden-Württemberg (6.6%) had the lowest. Small installment loans under 1,000 euros increased by 11% to 7.5 million contracts, partly due to Buy-Now-Pay-Later usage in online retail, while larger loans over 1,000 euros declined by 2%. Mortgage lending grew strongly, with new mortgage contracts up 25% to 1.12 million and total loan volume up 21% to 177.9 billion euros.
Fast Retailing posts record sales, profit up sharply
Fast Retailing, the parent company of Uniqlo, reported record results for fiscal 2026, with revenue up 16.6% to ¥3.96 trillion (€22.39 billion) and operating profit up 30.4% to ¥718.4 billion (€4.06 billion). Net profit attributable to shareholders rose 25.3% to ¥542.5 billion (€3.07 billion), marking the fifth consecutive year of record earnings. International expansion, particularly in Europe and North America, drove growth: Uniqlo International revenue grew 26.2% to ¥2.41 trillion, with Europe up 38.7% and North America up 34.6%. For the first time, combined Europe and North America revenue exceeded Greater China and other Asian markets. Japan and Greater China also grew. The company forecasts further growth in 2027, targeting revenue of ¥4.45 trillion and continued double-digit growth in international markets.
Ireland's Top-Funded Tech Companies in H1 2026
In H1 2026, Ireland's tech ecosystem raised approximately €630 million, ranking among Europe's top 10 by funding. The five largest rounds accounted for nearly three-quarters of the total. Wayflyer secured the largest transaction with a €212 million debt financing. Fintech and medical/healthcare companies attracted over €110 million each. Notable rounds included Fonoa's $110M Series C, Neurent Medical's €62.5M Series C, Equal1's $60M, Manna's $50M Series B, and others. Later-stage companies dominated, with Series C alone bringing in almost €157 million. The report highlights a mix of growth-stage and early-stage activity, though capital distribution remained uneven.
Track Real-Time Market Signals & Shifts
Set up custom watchlists to receive automated, evidence-grounded executive digests whenever material signals or shifts occur across your tracked landscape.